During the second quarter of 2020, WntResearch carried out a rights issue of so-called units in which one (1) unit consisted of two (2) new issued shares and one (1) warrant of series 2020/2021, issued free of charge. Those who subscribed for units during the subscription period from and including April 24, 2020 to and including May 8, 2020 thus received one (1) warrant of series 2020/2021, per subscribed unit in the rights issue. The exercise period for the warrants lasted during the period from and including February 8, 2021 to and including February 19, 2021. In accordance with the terms and conditions of the warrants, the subscription price for subscription of shares in WntResearch was set at SEK 0.81 per share.The outcome shows that a total of 9,836,359 warrants, corresponding to approximately 78 percent of the outstanding warrants, were exercised for subscription of 9,836,359 shares. Through the exercise of the warrants, WntResearch thus receives approximately SEK 8 million before issue costs, which amount to approximately SEK 0.4 million.Exercised warrants have been replaced with interim shares (IA) pending registration with the Swedish Companies Registration Office (Sw. Bolagsverket). The conversion of interim shares into shares is expected to take place within approximately three weeks. Through the exercise of the warrants, the total number of outstanding shares in WntResearch increases with 9,836,359 to 62,661,667 shares. Accordingly, the share capital increases with SEK 885,272.31 to SEK 5,639,550.03.CEO comment:"We are very pleased with the outcome and humbled by the great confidence this indicates for the revised business plan recently launched by the company. We have previously secured investors to carry out a rights issue of approximately SEK 55 million and are now further strengthening the Company's capital base, which creates an opportunity to  intensify the development of our drug candidate Foxy-5 ".AdvisersMangold Fondkommission AB is the financial adviser and Setterwalls Advokatbyrå AB is the legal adviser to WntResearch regarding the warrants.This disclosure contains information that WntResearch is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 23-02-2021 17:30 CET.WntResearch